Advances in Nanobiosystems for Complex Diseases
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 186
Special Issue Editor
Interests: drug delivery systems; solid lipid nanoparticles; nanomedicine; drug targeting; sphingolipids; cell signaling; cell proliferation; cell migration
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Complex diseases are pathological processes triggered by a combination of different factors (related to the environment, genetics, lifestyle, or unidentified factors) and are considered the most challenging diseases to treat. Therefore, complex diseases or pathological processes (cancer, neuropathies, multidrug resistance, or antibiotic resistance) require special efforts when it comes to developing efficient therapies. Nonetheless, recent developments in nanotechnology provide encouraging opportunities to design smart strategies for the visualization, diagnosis, or treatment of complex diseases.
This Special Issue will focus on the development of drug delivery systems designed to overcome biological barriers, increase drug efficiency, reduce side effects, improve combined therapy, or enable multitargeting strategies. Therefore, authors working on new therapeutic formulations to treat complex diseases are welcome to submit their contributions to this Special Issue entitled “Advances in Nanobiosystems for Complex Diseases”. We are especially interested in drug delivery systems that mimic structural and functional aspects of naturally occurring biological assemblies (cell membrane-based drug delivery systems, exosomes, lipid nanoparticles, liposomes, or micelles) and wish to showcase the most recent papers related to this innovative field.
Dr. Lide Arana
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- smart nanoparticles
- nanobiosystems
- lipid nanoparticles
- biomimetic nanostructures
- complex diseases
- cancer
- neuropathies
- multidrug resistance
- antibiotic resistance
- biological barriers
- combined therapy
- multitarget therapy
